zidovudine has been researched along with Leukemia, Lymphocytic, T Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, K; Namiki, M; Onodera, R; Saito, N; Takemori, N; Watanabe, S | 1 |
| Avramis, VI; Gomperts, E; Kwock, R; Solorzano, MM | 1 |
| Taguchi, H | 1 |
| Behm, FG; Broniscer, A; Gill, P; Head, DR; Mandrell, B; Raimondi, SC; Ribeiro, RC; Srinivas, RV | 1 |
| Bazarbachi, A; Hermine, O | 1 |
| Abul-Hajj, YJ; Akanni, AO; Ballato, G; Chang, S; Larson, RS; McIntee, EJ; Wagner, CR | 1 |
| Chou, TC; Stein, CA; Zhu, QY | 1 |
1 review(s) available for zidovudine and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
Topics: Adult; Antiviral Agents; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia, T-Cell; Recurrence; Zidovudine | 1996 |
1 trial(s) available for zidovudine and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
Topics: Adult; Antiviral Agents; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia, T-Cell; Recurrence; Zidovudine | 1996 |
6 other study(ies) available for zidovudine and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Suppression of HTLV-1-induced human leukemia cell infiltration by zidovudine.
Topics: Cell Movement; Human T-lymphotropic virus 1; Humans; Leukemia, T-Cell; Male; Middle Aged; T-Lymphocytes; Zidovudine | 1994 |
Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Topics: Adolescent; Adult; Antiviral Agents; Cell Division; Child; Child, Preschool; Clone Cells; Dideoxynucleotides; DNA, Neoplasm; Drug Resistance; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Infant; Leukemia, T-Cell; T-Lymphocytes; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured; Zidovudine | 1993 |
Radioimmunotherapy: promising treatment of aggressive adult T-cell leukemia?
Topics: Acute Disease; Adult; Chronic Disease; Clinical Trials as Topic; Disease-Free Survival; Humans; Immunologic Factors; Interferon-alpha; Leukemia, T-Cell; Remission Induction; Survival Analysis; Treatment Outcome; Zidovudine | 1996 |
An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine.
Topics: Adolescent; Antineoplastic Agents; Antiviral Agents; Blotting, Southern; Combined Modality Therapy; Female; Follow-Up Studies; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HTLV-I Infections; Humans; Interferon-alpha; Leukemia, T-Cell; Zidovudine | 1996 |
Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Female; Floxuridine; Humans; Leukemia, T-Cell; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; RNA-Directed DNA Polymerase; Tumor Cells, Cultured; Zidovudine | 1997 |
Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate.
Topics: Cell Line; Deoxycytidine; Dextran Sulfate; Drug Synergism; Drug Therapy, Combination; HIV-1; Humans; Interferon Type I; Leukemia, T-Cell; Recombinant Proteins; T-Lymphocytes; Thionucleotides; Tumor Cells, Cultured; Zidovudine | 1991 |